Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Dorval

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
CNS Drugs|March 13, 2021
Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis ProgramOlivier Corbeil, Stéphanie Corbeil, Michel Dorval, et al.
BMC Medical Genomics|June 27, 2021
Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findingsJude Emmanuel Cléophat, Michel Dorval, Zaki El Haffaf, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Disruptions in Cancer Care Due to the COVID-19 Pandemic and Fear of Cancer Recurrence in Women with Breast Cancer: A Mixed-Methods StudyClaudia Mc Brearty, Laurie Bisaillon, Michel Dorval, et al.
Familial Cancer|July 5, 2017
Issues related to family history of cancer at the end of life: a palliative care providers' surveyCatherine Gonthier, Sylvie Pelletier, Pierre Gagnon, et al.
Critical Reviews in Oncology/Hematology|May 10, 2024
Mapping inter-professional collaboration in oncogenetics: Results from a scoping reviewMaria-Eugenia Espinoza-Moya, Jason Robert Guertin, Arthur Floret, et al.
European Journal of Human Genetics : EJHG|January 21, 2011
Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and QuebecMichel Dorval, Catherine Noguès, Pascaline Berthet, et al.
Healthcare (Basel, Switzerland)|June 12, 2026
Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationMichel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted TherapyAriane Bélanger, Sue-Ling Chang, Jean-François Stephan, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 31, 2025
Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' ConcernsKatherine Cheung, Maxwell Brodie, Sue-Ling Chang, et al.
Human Genetics|June 26, 2023
Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian contextPalmira Granados Moreno, Terese Knoppers, Ma'n H Zawati, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
CNS Drugs|March 13, 2021
Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis ProgramOlivier Corbeil, Stéphanie Corbeil, Michel Dorval, et al.
BMC Medical Genomics|June 27, 2021
Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findingsJude Emmanuel Cléophat, Michel Dorval, Zaki El Haffaf, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Disruptions in Cancer Care Due to the COVID-19 Pandemic and Fear of Cancer Recurrence in Women with Breast Cancer: A Mixed-Methods StudyClaudia Mc Brearty, Laurie Bisaillon, Michel Dorval, et al.
Familial Cancer|July 5, 2017
Issues related to family history of cancer at the end of life: a palliative care providers' surveyCatherine Gonthier, Sylvie Pelletier, Pierre Gagnon, et al.
Critical Reviews in Oncology/Hematology|May 10, 2024
Mapping inter-professional collaboration in oncogenetics: Results from a scoping reviewMaria-Eugenia Espinoza-Moya, Jason Robert Guertin, Arthur Floret, et al.
European Journal of Human Genetics : EJHG|January 21, 2011
Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and QuebecMichel Dorval, Catherine Noguès, Pascaline Berthet, et al.
Healthcare (Basel, Switzerland)|June 12, 2026
Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationMichel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted TherapyAriane Bélanger, Sue-Ling Chang, Jean-François Stephan, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 31, 2025
Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' ConcernsKatherine Cheung, Maxwell Brodie, Sue-Ling Chang, et al.
Human Genetics|June 26, 2023
Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian contextPalmira Granados Moreno, Terese Knoppers, Ma'n H Zawati, et al.
Pageof 9